Lower-Dose Vitamin E Works as Well as Higher Doses in MASLD, VEDS Trial Finds
Highlights
• In a multicenter randomized placebo-controlled trial, 200 IU/day natural vitamin E lowered ALT nearly as much as 400 IU/day and 800 IU/day in adults with suspected MASH and elevated aminotransferases.
• ALT normalization was more frequent with vitamin E than placebo, while liver fat and stiffness improved numerically but not significantly.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.